ALPINE IMMUNE SCIENCES, INC. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ALPINE IMMUNE SCIENCES, INC. treasury stock, value, acquired, cost method for fiscal 2017 was $0.00.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2020-03-30 |